<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Oakenhurst Medical Practice</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Oakenhurst Medical Practice is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0601012AB&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine/lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>22</td>
      <td>Intermediate and long-acting insulins</td>
      <td>407</td>
      <td>0.05</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>37.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0601012ABAAAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Ins glargine 100u/ml / Lixis 33mcg/ml inj 3ml pf dispos dev : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0601012ABBBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 50microg/ml inj 3ml pf SoloStar pens : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0601012ABBBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 33microg/ml inj 3ml pf SoloStar pens : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0304010H0&amp;denomIds=3.4.1&amp;selectedTab=summary">Clemastine fumarate</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Antihistamines</td>
      <td>733</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>8.12</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0304010H0AAABAB&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Clemastine 1mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0601023AP&amp;denomIds=6.1.2&amp;selectedTab=summary">Canagliflozin/metformin</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>50</td>
      <td>Other antidiabetic drugs</td>
      <td>1579</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.53</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0601023APAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Canagliflozin 50mg / Metformin 1g tablets : 44</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0601023APAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Canagliflozin 50mg / Metformin 850mg tablets : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0802010N0&amp;denomIds=8.2.1&amp;selectedTab=summary">Mycophenolic sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Antiproliferative immunosuppressants</td>
      <td>21</td>
      <td>0.19</td>
      <td>0.01</td>
      <td>0.03</td>
      <td>7.13</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0802010N0AAAAAA&amp;denomIds=8.2.1&amp;selectedTab=summary" target="_blank">Mycophenolic acid 180mg gastro-resistant tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0802010N0AAABAB&amp;denomIds=8.2.1&amp;selectedTab=summary" target="_blank">Mycophenolic acid 360mg gastro-resistant tablets : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=1202010T0&amp;denomIds=12.2.1&amp;selectedTab=summary">Triamcinolone acetonide</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>58</td>
      <td>Drugs used in nasal allergy</td>
      <td>513</td>
      <td>0.11</td>
      <td>0.01</td>
      <td>0.02</td>
      <td>6.64</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=1202010T0AAAAAA&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Triamcinolone 55micrograms/dose nasal spray : 51</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=1202010T0BBAAAA&amp;denomIds=12.2.1&amp;selectedTab=summary" target="_blank">Nasacort 55micrograms/dose nasal spray : 7</a></div></td></tr></tbody></table>

        <h2>Prescribing where Oakenhurst Medical Practice is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0&amp;denomIds=3.1.1&amp;selectedTab=summary">Salbutamol</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1703</td>
      <td>Selective beta(2)-agonists</td>
      <td>2133</td>
      <td>0.80</td>
      <td>0.91</td>
      <td>0.05</td>
      <td>-2.36</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0AAAPAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose inhaler CFC free : 1305</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0AAAQAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 200micrograms/dose dry powder inhaler : 55</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0AABUBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 100micrograms/dose breath actuated inh CFC free : 133</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0BEAIAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 100micrograms/dose Evohaler : 120</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0BEAHAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Ventolin 200micrograms/dose Accuhaler : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0BIAGBU&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose Easi-Breathe inhaler : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0BWAABZ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 100micrograms/dose dry pdr inh : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0AAAXAX&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials : 22</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0AABGBG&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 2mg/5ml oral solution sugar free : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0BIAFAP&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salamol 100micrograms/dose inhaler CFC free (Teva) : 17</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0BWABAQ&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Easyhaler Salbutamol sulfate 200micrograms/dose dry pdr inh : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0301011R0AABDBD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Salbutamol 5mg/2.5ml nebuliser liquid unit dose vials : 15</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0704010U0&amp;denomIds=7.4.1&amp;selectedTab=summary">Tamsulosin hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>498</td>
      <td>Drugs for urinary retention</td>
      <td>640</td>
      <td>0.78</td>
      <td>0.92</td>
      <td>0.06</td>
      <td>-2.30</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0704010U0AAAAAA&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Tamsulosin 400microgram modified-release capsules : 466</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0704010U0BDAAAB&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Flomaxtra XL 400microgram tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0704010U0BIAAAA&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Pamsvax XL 400microgram capsules (Actavis) : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0704010U0AAABAB&amp;denomIds=7.4.1&amp;selectedTab=summary" target="_blank">Tamsulosin 400microgram modified-release tablets : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0802010G0&amp;denomIds=8.2.1&amp;selectedTab=summary">Azathioprine</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Antiproliferative immunosuppressants</td>
      <td>21</td>
      <td>0.38</td>
      <td>0.80</td>
      <td>0.19</td>
      <td>-2.28</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0802010G0AAAEAE&amp;denomIds=8.2.1&amp;selectedTab=summary" target="_blank">Azathioprine 50mg tablets : 8</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0703050A0&amp;denomIds=7.3.5&amp;selectedTab=summary">Levonorgestrel</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Emergency contraception</td>
      <td>1</td>
      <td>0.00</td>
      <td>0.62</td>
      <td>0.33</td>
      <td>-1.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0212000B0&amp;denomIds=2.12&amp;selectedTab=summary">Atorvastatin</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2906</td>
      <td>Lipid-regulating drugs</td>
      <td>5549</td>
      <td>0.52</td>
      <td>0.66</td>
      <td>0.08</td>
      <td>-1.69</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIjUlEQVR4nO2df6xXZR3HX4cfGokUaWAQclYgS5Nw1hTLSGRmHUQj+rHpVlrRCEUTlsdc6wezDq0ftmwQ/shVtrHSXHKcCXcjdepKkn6Z4o8dA9ZCARma9IunPz7Pjcu37wHuvef7fQ73vF/bs/u9sJ3z3nf3dZ5znudznidyziGEaAbDQgcQQnQPCS9Eg5DwQjQICS9Eg5DwQjQICS9Eg5DwQjQICS9Eg5DwQjQICS9Eg5DwZUSRao7FkGNE6ABicMRpPgU4BzgZmAa8BhgF7AN2AjuAp4HNwGPA40WW7AuTVoQm0sszJUSRw7kodIx2xGk+DlgEfBjYC9wH/AF4EtgFvAIMB8YC44Ap2MXgdGAqJv7dwN1Flmzrdn4RDglfRg2Fj9P8DcAXgfOBW4DbiizZ0s9jjATOAC4ALgK2ATcBdxZZ8o9qE4u6IeHLqJHwcZofBVwJLAa+CdxUZMneCo4bAWcBnwJmATcC3y+y5KXBHlvUEwlfRk2Ej9P8FOBHwG+A64oseaFD55kALAPmA9/AxP9XJ84lwiHhywgsvO99LweuAhYVWXJfl847AVgOnAlcWWTJ+m6cV3QHCV9GQOHjNH81cDM24v6xTvXqh8hwGvZs/ztgaZElL3Y7g6gezcPXjDjNY+BB4BngghCyAxRZ8hjWyz8JbIzT/MIQOUS1qIcvI0APH6f5bGz0fWmRJXd289wHI07zk7Bc24DFRZbsCBxJDBAJX0YXhffP61cBC4EFRZb8qRvn7Q9xmg/DxhSWAJcVWXJ/4EhiAEj4MrokfJzmo7Bn5bHAxXV/Vo7TfAZwO7AGuL7Ikv8EjiT6gZ7hAxKn+WTseb0A5tVddoAiSzZhhTtvAnriNJ8YOJLoB+rhy+hwDx+n+TnArcCyIkvu6NR5Okmc5pcAXwEuL7LkntB5xKGR8GV0SHj/vL7Ytw8VWfLHqs/RTfyA3hpgHVYYpGKdGqNb+i7i69i/h9Wwn3Wkyw5QZMlmrDz3WGBDnOYnBo4kDoJ6+DIq7uHjNB8L/BR4ClgyFHvCOM0/AmRYhd4vQucR/4+EL6NC4eM0nwrcBawCbiyyZMh+6f79/J8Am7B6gj2BI4k+SPgyKhK+TzHNoiJL7h18sPrjH12uBS4GPlNkSU/gSMIj4cuoQPg4zRcCVwPziyx5vJpgRw6+Hn818ATW228PHKnxSPgyBiF8nOYjsFdMTwM+GKoevg7EaT4cm5FYij3SfKfIkr+HTdVcJHwZAxQ+TvPjsGmqZ7H56X9Wnu0IxH8vnwc+AHwVW63n32FTNQ8JX8YAhI/TfDo2En8DsGooD84NFP824HJgBvBl4Ocqz+0eEr6Mfgofp/kC4OvAx/ViyaHxNfnXAW8Fvg38sIplu8TBkfBlHKbwfkR6OTAHG5z7S8ezDSH8lOVSbGHO1cDqJo95dBoJX8ZhCO//WG8HHsVq4jUYNUDiNB8PXAFcgn2fPwB+qef8apHwZRxEeD/yfAW2kqyqyirEz3C8F7gUeDs2APozYKM20Bg8Er6MEuHjND8dWInNLV+t28/OEaf58cBHgQuxjTTWYRtorNdS2gNDwpfRIrx/7/t6rNf5bJEl64JlayBxmo8BzgPmAudi22f1AOuBR3Xrf3hI+DK88HGanwB8DluvfQW2CYT+uALil9uajok/B3gb8Gv2XwCe0JRoeyR8GVHk4mvWrgTej+3IsrLIkpcDpxJt8DvznInJPweYAPwKuwD0aP+8/Uj4Pvg/nLnAJ4sVc98XX7P208CPNfp+ZOFv/2dh8p+LrfvQ2/s/VGTJ8wHjBaXxwsdp/ipgNrYoxfnYGnM3Fyvm9tRhqykxePxuOrOxC8A7sA0+/oztuPt7//mpIkt2BgvZJRopfJzmk7AeYB62WssD2Pvq9xZZshsIvtWU6Bxxmh8NvAU41bdpwEnYhaAANre0p4fKXd6QF97P607DxD4beBewB7gfWAtsaLtNsoRvHP5vZTImf982FYiwmYG+F4JngK1H0hThkBHeP39PAmLs6j0DG719I7as1MOY5A8VWbLrkAeU8KIPfv+AN3PghWAKMBE4BngB2IrtzrO15fNfgR11KByqlfC+gu0YYHRLO9b/HINt2PC6Pm08dlWOgC3svyXb5NtzA5qikfDiMPErER+HdS4T/c/ez5OAE/z/O+B54G8lbRfwYm/rxLqH/RI+TvNl2Ihnb4tKPg8DRgJHtbSRwNHAKPZLPNr/DrAPeBl4ybc9fT73/r6zpW0HtlT+ppWEFxXjHxmOxzqp8diFoPfzOOC1LW0E5sRuzItX+rS9vZ+LLFl8uBk60sNHUbTQObe68gNXQJ2zgfINhjpng3rk69S69As7dNwqqHM2UL7BUOdsUIN82ohCiAYh4YVoEJ0SvrbPUdQ7GyjfYKhzNqhBvlpNywkhOotu6YVoECOqOEgURe/GSle3O+du9f+2CrjNOfdIFecYDK35oij6ElbccI9zbnPNsp0NzAQecc4FX/22Tb6LgJOBUc65L4RN1zbfJ7AaD5xzN9Qs22XY/Ppzzrk7QmSqqoef6ZzLgNcDRFE0H9hQ0bGr4IB8wA6soq8OtGabhxVUBC/D9ByQzzl3F1ZDviZoqv20fn/DsUKWOmxr1ZrtROfct7C3MoNQlfCtAwHTsZdU3lnR8QfLAfmcc98FvgYsCBPnAFq/uzE+33khwrSh3SDPqc65uuxt35pvmHPuWqzuPTSt2XqiKFqCVc4FoZJBO3/rMhMrdf2tc25jFEXvAfbW6Jb+f/mwFx9OAR50zgXd0bVNtsnYC0C7nXO3BIwGtM33LHCp76mC0ybfLKzMe0/oqrY22UYDZwAPO+ceCJJJo/RCNAeN0gvRICS8EA1CwgvRICS8EA1CwgvRICS8EA1CwgvRICS8EA1CwgvRICS8EA1CwgvRIP4LB2eBKhExx70AAAAASUVORK5CYII="></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0212000B0AAAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 10mg tablets : 483</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0212000B0AAABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 20mg tablets : 1238</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0212000B0AAACAC&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 40mg tablets : 819</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0212000B0AAADAD&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Atorvastatin 80mg tablets : 346</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0212000B0BBABAB&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Lipitor 20mg tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0212000B0BBAAAA&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Lipitor 10mg tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P81125&amp;numIds=0212000B0BBACAC&amp;denomIds=2.12&amp;selectedTab=summary" target="_blank">Lipitor 40mg tablets : 5</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>